1. Inhibitory Effects of Citronellol and Geraniol on Nitric Oxide and Prostaglandin E2Production in Macrophages
- Author
-
Tsang-Yow Ou, Meng-Hwan Lee, Shiou-Huei Chao, Yu-Wen Su, and Ying-Chieh Tsai
- Subjects
Pharmacology ,Citronellol ,biology ,Monoterpene ,medicine.medical_treatment ,Organic Chemistry ,Pharmaceutical Science ,Analytical Chemistry ,Nitric oxide ,Nitric oxide synthase ,chemistry.chemical_compound ,Complementary and alternative medicine ,chemistry ,Biochemistry ,Drug Discovery ,medicine ,biology.protein ,Molecular Medicine ,Prostaglandin E2 ,Geraniol ,Unsaturated fatty acid ,Prostaglandin E ,medicine.drug - Abstract
Geranium oil has been used traditionally for diarrhea, dermatitis, and intestinal inflammation in East Asia. The aim of this study was to determine the effects of geranium oil's characteristic components, citronellol and geraniol, on lipopolysaccharide (LPS)-induced nitric oxide (NO) and prostaglandin E(2) (PGE(2)) production in RAW 264.7 macrophages. Citronellol and geraniol suppressed NO and PGE(2) production in a dose-dependent manner. The inhibitory efficacy of geraniol was concomitant with decreases in protein and mRNA expression levels of inducible nitric oxide synthase (iNOS), whereas citronellol inhibited only iNOS enzymatic activity. By adding citronellol and geraniol, the LPS-induced cyclooxygenase-2 (COX-2) protein and mRNA expression levels were significantly attenuated, whereas cytosolic degradation of I κB α and upregulation of NF-κB p65 in the nucleus were reversed. These results suggested that citronellol and geraniol exhibit anti-inflammatory activities, supporting their common use and demonstrating their therapeutic potential for inflammation-associated disorders.
- Published
- 2010
- Full Text
- View/download PDF